· Investment Strategies · 3 sources
MIND Raises $72M Series B — DLP Rebuilt for GenAI and Agents
Crosspoint Capital led MIND’s $72M Series B ($112M total). Ctech cites ~$300M mark and ~$10M ARR run rate — who uses AI-native DLP and why a cyber specialist led.
By Venture Capital Tracker Editorial
MIND raised a $72 million Series B announced September 17, 2026, led by Crosspoint Capital Partners, with YL Ventures and Paladin Capital Group returning. Company-disclosed total funding is now $112 million.
classic DLP was built for email and endpoints; GenAI and agents moved sensitive data into channels legacy tools barely see — MIND is selling that rewrite, with named healthcare and media buyers.
Key facts
- Company
- MIND — Seattle HQ; R&D in Israel
- Round
- $72M Series B · $112M total (company)
- Date
- September 17, 2026
- Lead
- Crosspoint Capital Partners (~$35M of the round per Ctech)
- Returning
- YL Ventures, Paladin Capital Group
- Prior
- $30M Series A ~1 year earlier (company)
- Valuation
- Not in PR. Ctech / company sources: ~$300M
- Revenue
- PR: 17× revenue / 8× customers YoY; “eight-figure.” Ctech: ~$10M ARR run rate
- Named customers
- Children’s Hospital Los Angeles; National Geographic Society
- Use of proceeds
- Product (Stress Free DLP / AI DLP Agents), enterprise GTM, partnerships, hiring
Who uses the product — and for what job
Users: security and IT leaders who must let staff use ChatGPT-class tools and agents without leaking PHI, IP, or regulated content.
Jobs:
- Discover and classify sensitive data across SaaS, GenAI, agents, endpoints, shares, email
- Autonomously investigate / remediate / block via AI DLP agents
- Keep AI adoption moving (hospital CIO framing) while blocking PHI into AI tools
CHLA’s CIO quote is the buyer voice: protect patient data without performance hits that kill AI pilots. NatGeo’s quote is the media/IP variant — label documents and see when data touches AI agents.
Why now
- Company PR cites industry stats it attributes to the AI-adoption wave (90% GenAI deployment; weak confidence in AI data controls) — treat as cited context, not MIND’s own metrics.
- Round timing is ~12 months after Series A — Crosspoint doubling down after an RSAC Innovation Sandbox finalist path (company + Ctech).
- Ctech’s ~$10M ARR run rate against a ~$300M reported mark is the diligence tension: strong growth claims, still early absolute revenue.
Why Crosspoint — portfolio fit
Crosspoint is a cybersecurity specialist (Ctech notes Greg Clark / Symantec lineage; portfolio names like McAfee and Forescout). Leading ~half the round (Ctech) after a smaller prior check is a category-define bet on AI-native DLP, not a generalist SaaS spray.
YL Ventures and Paladin returning keep Israeli cyber continuity and prior diligence.
**
| Investor type | What they bring |
|---|---|
| Crosspoint | Cyber underwriting + Series B size |
| YL / Paladin | Prior-round continuity; Israel/US cyber network |
Strategic rationale: pick a lead that already lives in enterprise security budgets, keep existing holders whole (Ctech: no secondary), and raise enough to hire into US enterprise markets without selling the company early.
Competitive map
| Player | Lane |
|---|---|
| Legacy DLP (Symantec/Broadcom, Forcepoint, Microsoft Purview) | Broad suites; slower AI-channel coverage |
| DSPM / data security startups | Overlap on discovery; MIND pitches unified DLP + IRM autopilot |
| Upwind / cloud CNAPP | Cloud workload security — adjacent, not classic DLP |
| Guardio | Consumer cyber — different buyer |
Missing / labeled carefully
- Valuation and ARR are Ctech-attributed, not in the PR Newswire release.
- “Dozens of customers” vs “hundreds of thousands of endpoints” — different denominators; do not invent logo count.
- Founded 2023 per Ctech (Hexadite / Unit 8200 pedigree) — use that over marketing adjectives.
Practical takeaway
- Founders (cyber): Named regulated buyers beat “AI security” slogans.
- Investors: Separate company growth multiples from absolute ARR; ask for GenAI-channel false-positive rates.
- CISOs: Ask whether the tool sees agent and SaaS paths, not only email DLP policies from 2018.
Follow Venture Capital Tracker on Google
Add VCT as a preferred source to see more of our venture-capital reporting in Google Search.
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.
